Preclinical Imaging (In-VIVO) Market Research Report

Preclinical Imaging (In-VIVO) Market Analysis & Forecast 2023-2029

Preclinical Imaging (In-VIVO) Market by Techniques ( MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography) Micro-CT (Micro Computed Tomography), Optical imaging and Magnetic particle (MPI)) by Application ( Oncology, Neurology, Cardiology, Inflammation, Infectious diseases, Cancer research, Functional and Anatomical Neuroimaging, Orthopedics, Cardiac imaging and Stroke models) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2023-2029

Number of pages: 138 | Report Code: PSMR- PSMR-00540 | Report Format : PDF

Preclinical Imaging (In-VIVO) Market is expected to reach 1401.86 million by 2027 at CAGR of 4.92%. Preclinical imaging is medical process of visualization of living animals for purpose of research, such as new medical procedure and drug development . In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes.  


In application aspect, vivo imaging is increasingly deployed across the drug development process, with applicability in target identification, compound optimisation and pre-Phase I studies. In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key diseases/therapeutic areas targeted with in vivo preclinical imaging by survey respondents were oncology/cancer (70% targeting). This was followed by inflammatory disease/autoimmune (36% targeting), neurology / CNS / neurodegeneration/ pain (32% targeting) and then cardiovascular (25% targeting)  


Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. The most suitable modalities for small-animal in vivo imaging applications are based on nuclear medicine techniques (essentially, positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound  


Geographically, Preclinical Imaging (In-VIVO) Market categorised in North America, Europe, China, Japan, South East Asia, India and Rest of World. North America holds the highest sale volume of market. Increased in Pharmaceutical research, New development in biotechnology, government support for various research work and advancement in technology are the prime factor driving the Preclinical Imaging (In-VIVO) Market globally. Europe and Asia –Pacific market is expected to grow at higher CAGR in forecasted years. African market expected to grow at lower rate while Middle East and South American market is expected to show constant growth rate.  


Global Preclinical Imaging (In-VIVO) Market Report
 


Preclinical Imaging (In-VIVO) Market: Techniques Type

  • MRI (Magnetic Resonance Imaging)
  • PET (Positron Emission Tomography)
  • SPECT (Single Photon Emission Computed Tomography)
  • Micro-CT (Micro Computed Tomography)
  • Optical imaging and Magnetic particle (MPI)

Preclinical Imaging (In-VIVO) Market: Vessel Type

  • Oncology
  • Neurology
  • Cardiology
  • Inflammation
  • Infectious diseases
  • Cancer research
  • Functional and Anatomical Neuroimaging
  • Orthopedics
  • Cardiac imaging
  • Stroke models

Preclinical Imaging (In-VIVO) Market : Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Preclinical Imaging (In-VIVO) Market:

  • PerkinElmer
  • Bruker Corporation
  • FUJIFILM Holdings
  • Mediso
  • MILabs B.V.
  • MR Solutions
  • Aspect Imaging
  • LI-COR Biosciences
  • Trifoil Imaging
  • Miltenyi Biotec

Geographical analysis of Preclinical Imaging (In-VIVO) Market:

  • North America
    • U.S.A
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
  • Latin America
    • Brazil
  • Middle East and Africa

Preclinical Imaging (In-VIVO) Market Report delivers a comprehensive analysis of the following parameters :

  • Market Forecast for 2018-26
  • Market growth drivers
  • Challenges and Opportunities
  • Emerging and Current Market trends
  • Market player Capacity, Production, Revenue (Value)
  • Supply (Production), Consumption, Export, Import analysis
  • End-user/application Analysis


Preclinical Imaging (In-VIVO) Market by Techniques ( MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography) Micro-CT (Micro Computed Tomography), Optical imaging and Magnetic particle (MPI)) by Application ( Oncology, Neurology, Cardiology, Inflammation, Infectious diseases, Cancer research, Functional and Anatomical Neuroimaging, Orthopedics, Cardiac imaging and Stroke models) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast


Preclinical Imaging (In-VIVO) Market Report delivers a comprehensive analysis of the following parameters:

  • Market Estimates & Forecast from 2023 to 2029

  • Market Intelligence to consolidate decisions

  • Market growth drivers, emerging and current market trends

  • Challenges and Opportunities overview

  • In-detailed segment & End user/application analysis

  • Top player Production insight, Revenue (Value), market share, recent developments & future outlook

  • Supply (Production), Consumption, Export-Import analysis

  • Covid 19 impact & sustainability strategies in a post-pandemic market

Report Coverage

Parameters Details

Base Year

2022

Historical Data

2017-2022

Forecast Data

2023-2029

Regional Scope

North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW

Frequently Asked Questions (FAQ)


Preclinical Imaging (In-VIVO) Market report considers 2021 as the base year.




Preclinical Imaging (In-VIVO) Market report considers data for period 2016 to 2021 as the historical data to predict market forecast between 2022 to 2029.




Yes, report is inclusive in-detailed analysis of key players in Preclinical Imaging (In-VIVO) Market




Preclinical Imaging (In-VIVO) Market Study is broadly divided into North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW. Also these regions are further analysed as per various countries




Preclinical Imaging (In-VIVO) Market Report includes Market Segmentation, Regional outlook, Application Analysis, Competitive analysis, Supply-Demand Analysis, Pricing insight.




Yes, the report includes COVID 19 impact on the market.




Top

  Download Free Sample


    ×

    Select Licence Type
    Preclinical Imaging (In-VIVO) Market Research Report

      Single User -          $2550


      Corporate User -   $3550


    Why Profshare Market Research?

      High Data Accuracy

    Precise research methodology, numerous analysis models & up to date data resources to achieve the most accurate market values.


     Free Customization

    We can tailor the report as per your requirements & budget, Most of our clients prefer custom reports.


      Budget-Friendly Solutions

    We have quality market data for all types of budgets & so now get the best out of your market research budget.


      Quality Support

    Be assured regarding satisfactory analyst support & understand the research report in-detailed.

    Latest Medical Devices Reports